 |
|
Microcontact Printing on Human Tissue for Retinal Cell Transplantation
Christina J. Lee, MS;
Philip Huie, MS;
Theodore Leng, MS;
Mark C. Peterman, MS;
Michael F. Marmor, MD;
Mark S. Blumenkranz, MD;
Stacey F. Bent, PhD;
Harvey A. Fishman, MD, PhD
Arch Ophthalmol. 2002;120:1714-1718.
Objectives To demonstrate that microcontact printing, a modern materials fabrication technique, can be used to engineer the surface of human tissue and to show that inhibitory molecules can be used to pattern the growth of retinal pigment epithelial cells or iris pigment epithelial cells on human lens capsule for transplantation.
Methods Photolithographic techniques were used to fabricate photoresist-coated silicon substrates into molds. Poly(dimethylsiloxane)stamps for microcontact printing were made from these molds. The poly(dimethylsiloxane) stamps were then used to "wet-transfer" growth inhibitory molecules to the surface of prepared human lens capsules that were obtained during cataract surgery. Human retinal pigment epithelial and rabbit iris pigment epithelial cells were grown on a lens capsule substrate in the presence and absence of a patterned array of inhibitory factors.
Results We found that human lens capsule could be microprinted with a precision similar to that obtained on glass or synthetic polymers. Retinal pigment epithelial cells and iris pigment epithelial cells cultured onto an untreated lens capsule showed spreading and formed into fusiform-appearing cells. In contrast, cells cultured on a lens capsule with a hexagonal micropattern of growth inhibitory molecules retained an epithelioid form within the inhibitory hexagons.
Conclusion Inhibitory growth molecules can be micropatterned onto human lens capsule, and these micropatterns can control the organization of retinal pigment epithelial cells or iris pigment epithelial cells cultured onto the lens capsule surface.
Clinical Relevance Microprinting on autologous human tissue may facilitate efforts to effectively organize cell cultures and transplantations for the replacement of vital ocular tissues such as the retinal pigment epithelium in age-related macular degeneration.
From the Departments of Chemical Engineering (Ms Lee and Dr Bent), Ophthalmology (Messrs Huie and Leng and Drs Marmor, Blumenkranz, and Fishman), and Applied Physics (Mr Peterman), Stanford University, Stanford, Calif.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Use of iris pigment epithelium to replace retinal pigment epithelium in age-related macular degeneration: a gene expression analysis.
Cai et al.
Arch Ophthalmol 2006;124:1276-1285.
ABSTRACT
| FULL TEXT
Directed Retinal Nerve Cell Growth for Use in a Retinal Prosthesis Interface
Leng et al.
IOVS 2004;45:4132-4137.
ABSTRACT
| FULL TEXT
|
